DAO and fatty liver disease: Circulating DAO concentrations were positively associated with liver steatosis severity assessed with CAP (Rho = 0.22, p = 0.02; Table 3) and its degree (38.9 ng/mL in S1–S2 group vs. 49.0 ng/mL in S3 group, p = 0.04; Table 4).